'''JTE-907''' is a drug used in scientific research that acts as a selective [[cannabinoid receptor 2|CB<sub>2</sub>]] [[inverse agonist]].<ref>{{cite journal |author= Iwamura, H|title= In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor |journal= The Journal of Pharmacology and Experimental Therapeutics |volume= 296 |issue= 2 |pages= 420–5 |year= 2001 |pmid= 11160626 |display-authors=etal}}</ref><ref>{{cite journal |author= Raitio, KH|title= Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists |journal= Journal of Medicinal Chemistry |volume= 49 |issue= 6 |pages= 2022–7 |year= 2006 |pmid= 16539390 |doi= 10.1021/jm050879z |display-authors=etal}}</ref> It has [[antiinflammatory]] effects in animal studies,<ref>{{cite journal |author= Ueda, Y|title= Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice |journal= European Journal of Pharmacology |volume= 520 |issue= 1–3 |pages= 164–71 |year= 2005 |pmid= 16153638 |doi= 10.1016/j.ejphar.2005.08.013 |display-authors=etal}}</ref> thought to be mediated by an interaction between the CB<sub>2</sub> receptor and [[IgE]].<ref>{{cite journal |last1= Ueda |first1= Y |last2= Miyagawa |first2= N |last3= Wakitani |first3= K |title= Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice |journal= Life Sciences |volume= 80 |issue= 5 |pages= 414–9 |year= 2007 |pmid= 17055000 |doi= 10.1016/j.lfs.2006.09.026 }}</ref>
